A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
The Fibrinolytic Response To Stanozolol In Normal Subjects
1981
Thrombosis and Haemostasis
It has been recognized for a number of years that fibrinolytic activity in patients with various forms of vascular disease may be enhanced by stanozolol (17-β-hydroxy-17α-methyl adrostano {3.2,- c } pyrazole ). However, little is known of its effect in normal healthy individuals. Also it is not known how quickly the drug exerts its effects. Two groups of eight normal healthy adults were studied. Seven subjects were included in both groups. Group A received stanozolol 5mgs b.d. Group B received
doi:10.1055/s-0038-1653174
fatcat:w6im6ijs5fgtzig5rrax6adovu